4-(3,3-Difluoroazetidin-1-yl)piperidine

Catalog No. :
ACGDAO410
CAS No. :
1093066-73-9
Molecular Formula :
C8H14F2N2
Molecular Weight :
176.21

IUPAC Name:4-(3,3-difluoroazetidin-1-yl)piperidine

4-(3,3-Difluoroazetidin-1-yl)piperidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$79.00Login to see priceIn stockIn stock
250mg98%$165.00Login to see priceIn stockIn stock
1g98%$395.00Login to see priceIn stockIn stock
5g98%$1316.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3,3-Difluoroazetidin-1-yl)piperidine
IUPAC Name4-(3,3-difluoroazetidin-1-yl)piperidine
MDL No.MFCD17215901
Molecular FormulaC8H14F2N2
Molecular Weight176.21
SMILESFC1(F)CN(C1)C1CCNCC1
InChI KeyNMSGIIPUOLDNTO-UHFFFAOYSA-N
Synonym4-(3,3-difluoroazetidin-1-yl)piperidine hydrochloride;4-(3,3-Difluoro-azetidin-1-yl)-piperidine;4-(3,3-Difluoro-1-azetidinyl)piperidine;Piperidine, 4-(3,3-difluoro-1-azetidinyl)-
CAS No.1093066-73-9

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGDAO410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGDAO410 route product structure diagram
    ACGDAO4101093066-73-9 In Stock
Inquiry

2. ACGDAO410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2 In Stock
  6. Then
  7. ACGDAO410 route product structure diagram
    ACGDAO4101093066-73-9 In Stock
Inquiry

Comments (0)